期刊文献+

系统性红斑狼疮细胞与其病情活动性的相关性研究 被引量:2

Research on the correlation between lupus erythematosus cell and diseases activity in patients with systemic lupus erythematosus
原文传递
导出
摘要 目的观察系统性红斑狼疮(SLE)患者外周血狼疮细胞(LEC)形态的变化,探讨其与SLE疾病活动性的关系。方法采用经典改良血块法观察了50例SLE疾病活动期和30例SLE非活动期患者外周血LEC形态,同时与血清自身抗体、补体及SLE疾病活动指数(SLEDAI)对比研究。结果特殊形态的LEC与自身抗体的抗dsDNA抗体和抗核小体抗体(AnuA)(r=0.588,P=0.056;r=0.759,P=0.135),补体C3和C4(r=-0.648,P=0.058;r=-0.589,P=0.057)及SLEDAI(r=0.686,P<0.05)具有明显相关性。SLE活动期组特殊型LEC、自身抗体和补体与SLE非活动期组差异有统计学意义(P<0.01)。当自身抗体和补体与SLEDAI无相关性时,特殊型LEC仍具有良好的相关性(r=0.786,P<0.05)。结论特殊型LEC与自身抗体、补体及SLEDAI有明显的相关性,可作为判断SLE疾病活动性的独特指标。 Objective To observe the morphologic changes of peripheral blood lupus cell in patients with systemic lupus erythematosus and investigate its relationship with disease activity in systemic lupus erythematosus. Methods Modified classical blood clotting method to observe the morphological changes of peripheral blood lupus cells in 80 cases with systemic lupus erythematosus. Fifty cases were in active stage, and 30 cases were in stable stage. Comparison of serum autoantibody, complement and SLEDAI were also carried out. Results There was significant association between lupus cells in special morphous and autoantibody, such as anti-double-stranded DNA antibody, anti-nucleosome antibodies, complement C3,C4 and SLEDAI (r= 0.588, P=0.056; r=0.759, P=0.135; r=-0.6d8, P=0.058; r=-0.589, P=0.057; r=0.686, P〈0.05). There was significant difference in special morphous LEC, autoantibody and complement between the active disease group and the stable patients (P〈0.01). Although there was no association between autoantibody, complemenl and SLEDAI, the LEC in special morphous still associatied with SLEDAI. Conclusion There is a significant association between special morphous LEC and autoantibody, complement as well as SLEDAI and it may be a special parameter that can be used to evaluate the disease activity in SLE patients.
出处 《中华风湿病学杂志》 CAS CSCD 2007年第8期477-479,513,共4页 Chinese Journal of Rheumatology
基金 第四军医大学西京高新基金(XJGX04045L11)
关键词 红斑狼疮 系统性 自身抗体 狼疮细胞 SLE疾病活动指数 Lupus erythematosus, systemic Autoantibodies Lupus cells SLEDAI
  • 相关文献

参考文献6

  • 1Benucci M, Gobbi FL, del Rosso A, et al. Disease activity and antinucleosome antibodies in systemic lupus erythematosus. Scand J Rheumatol, 2003, 32: 42-45.
  • 2李胜光,黄烽.系统性红斑狼疮的生物标记[J].中华风湿病学杂志,2005,9(4):250-253. 被引量:3
  • 3Hochberg MC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 1997, 40: 1725.
  • 4Bombardier C, Gland DD, Urowitz MB, et al. Derivation of the SLEDAI:a disease activity index for lupus patients. Arthitis Rheum, 1992, 35: 630-640.
  • 5丁雪芹,周康兴,孙凌云.系统性红斑狼疮T细胞活化及其与病情活动的相关性研究[J].中华风湿病学杂志,2006,10(6):327-330. 被引量:5
  • 6Bluestein H. Neuropsychiatric disorders of SLE//Lahita RD. Systemic lupus erythematosus. 2nd. New York: Academic Press, 1992: 639-656.

二级参考文献34

  • 1肖东杰,刘洋,黄平,李晓英,杨博,汪运山.淋巴细胞活化在系统性红斑狼疮发病中的意义[J].中国麻风皮肤病杂志,2004,20(6):528-530. 被引量:2
  • 2Ho A, Magder LS, Barr SG, et al. Decreases in anti-doublestranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus. Arthritis Rheum, 2001,44: 2342-2349.
  • 3Illei GG, Tackey E, Lapteva L, et al. Biomarkers in systemic lupus erythematosus(Ⅰ): general overview of biomarkers and their applicability. Arthritis Rheum, 2004, 50: 1709-1720.
  • 4Nagy G, Brozik M, Tornoci L, et al. Diagnostic value of combined evaluation of neopterin and anti-DNA antibody levels for assessment of disease activity in systemic lupus erythematosus. Clin Exp Rheumatol, 2000, 18: 699-705.
  • 5Mollnes TE, Haga H J, Brun JG, et al. Complement activation in patients with systemic lupus erythematosus without nephritis.Rheumatology (Oxford), 1999, 38: 933-940.
  • 6Andersen LS, Petersen J, Svenson M, et al. Production of IL-1β,IL-1 receptor antagonist and IL-10 by mononuclear cells from patients with SLE. Autoimmunity, 1999, 30: 235-242.
  • 7Dejica D. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases: effect of immunosuppressive therapy. Roum Arch Microbiol Immunol, 2001, 60: 183-201.
  • 8Nishitani Y, Kubo A, Iwano M, et al. Imbalance between interleukin-6 and adrenomedullin mRNA levels in peripheral blood mononuclear cells of patients with lupus nephritis. Clin Exp Immunol, 2001, 124: 330-336.
  • 9Yin Z, Bahtiyar G, Zhang N, et al. IL-10 regulates murine lupus.J Immunol, 2002, 169: 2148-2155.
  • 10Amerio P, Frezzolini A, Abeni D, et al. Increased IL-18 in patients with systemic lupus erythematosus: relations with Th-1,Th-2, pro-inflammatory cytokines and disease activity: IL-18 is a marker of disease activity but does not correlate with pro-inflammatory cytokines. Clin Exp Rheumatol, 2002, 20: 535-538.

共引文献5

同被引文献11

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部